These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 11362747)
1. Clarithromycin prophylaxis against disseminated Mycobacterium avium complex in patients with AIDS. Archange YR; Carrey Z; Zanlungo PG J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):20-2. PubMed ID: 11362747 [TBL] [Abstract][Full Text] [Related]
2. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871 [TBL] [Abstract][Full Text] [Related]
3. Abbott files SNDA for MAC prophylaxis. J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):32. PubMed ID: 11362606 [TBL] [Abstract][Full Text] [Related]
4. The role of clarithromycin in the prophylaxis of disseminated Mycobacterium avium-intracellulare infection in patients with AIDS. Mertl SL Pharmacotherapy; 1996; 16(3):393-400. PubMed ID: 8726597 [TBL] [Abstract][Full Text] [Related]
5. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS. Cohn DL Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195 [TBL] [Abstract][Full Text] [Related]
6. Antivirals key to MAC prevention regimen. AIDS Alert; 1996 Sep; 11(9):101-3. PubMed ID: 11363722 [TBL] [Abstract][Full Text] [Related]
7. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis. Aberg JA; Wong MK; Flamm R; Notario GF; Jacobson MA HIV Clin Trials; 2001; 2(6):453-9. PubMed ID: 11742432 [TBL] [Abstract][Full Text] [Related]
8. Prophylaxis against disseminated Mycobacterium avium complex in AIDS. Ong EL J Infect; 1999 Jan; 38(1):6-8. PubMed ID: 10090497 [No Abstract] [Full Text] [Related]
9. MAC prophylaxis revisited. Torres G GMHC Treat Issues; 1996 Apr; 10(4):6-7, 10. PubMed ID: 11363706 [TBL] [Abstract][Full Text] [Related]
10. Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease. Hewitt RG; Papandonatos GD; Shelton MJ; Hsiao CB; Harmon BJ; Kaczmarek SR; Amsterdam D AIDS; 1999 Jul; 13(11):1367-72. PubMed ID: 10449290 [TBL] [Abstract][Full Text] [Related]
11. Clarithromycin prophylaxis against Cryptosporidium enteritis in patients with AIDS. Jordan WC J Natl Med Assoc; 1996 Jul; 88(7):425-7. PubMed ID: 8764523 [TBL] [Abstract][Full Text] [Related]
12. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team. Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562 [TBL] [Abstract][Full Text] [Related]
13. Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. Bui KQ; McNabb J; Li C; Nightingale CH; Nicolau DP Antimicrob Agents Chemother; 1999 Sep; 43(9):2302-4. PubMed ID: 10471584 [TBL] [Abstract][Full Text] [Related]
14. Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome. Barradell LB; Plosker GL; McTavish D Drugs; 1993 Aug; 46(2):289-312. PubMed ID: 7691518 [TBL] [Abstract][Full Text] [Related]
15. Controversies in the management of Mycobacterium avium complex infection in AIDS patients. Peloquin CA Ann Pharmacother; 1993; 27(7-8):928-37. PubMed ID: 8364280 [TBL] [Abstract][Full Text] [Related]
16. Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS. Craft JC; Notario GF; Grosset JH; Heifets LB Clin Infect Dis; 1998 Oct; 27(4):807-12. PubMed ID: 9798037 [TBL] [Abstract][Full Text] [Related]
17. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Dautzenberg B; Truffot C; Legris S; Meyohas MC; Berlie HC; Mercat A; Chevret S; Grosset J Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):564-9. PubMed ID: 1832527 [TBL] [Abstract][Full Text] [Related]
18. Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease. Dautzenberg B Drugs; 1997; 54 Suppl 2():1-7; discussion 28-9. PubMed ID: 9358194 [TBL] [Abstract][Full Text] [Related]
19. Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin. Doucet-Populaire F; Truffot-Pernot C; Grosset J; Jarlier V J Antimicrob Chemother; 1995 Jul; 36(1):129-36. PubMed ID: 8537260 [TBL] [Abstract][Full Text] [Related]
20. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS. Wright J Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]